Beijing Zhaoyan New Drug Research Center Co., Ltd.
JOINN Laboratories（China）CO., Ltd.

Beijing Zhaoyan New Drug Research Center Co., Ltd. (Zhaoyan New Drug, stock code: 603127. SH/6127. HK), founded in 1995, is a specialized drug research and development service outsourcing enterprise (CRO). The group is headquartered in Beijing and has subsidiaries in Beijing, Suzhou, Chongqing, Wuzhou, Guangzhou, Shanghai, San Francisco, California, and Boston, Massachusetts, with a large-scale professional technical team. Zhaoyan New Drug has established a quality management system (CNAS/ILAC-MRA certification) that complies with international standards. It has GLP qualifications from China NMPA, US FDA, Japan PMDA, South Korea MFDS, and OECD, as well as international AAALAC (Animal Welfare) certification qualifications. The evaluation data meets global drug registration requirements. The group company provides non clinical pharmacological and toxicological research and evaluation services to global clients, particularly in non clinical safety evaluation, clinical trials, and drug vigilance; We can also provide customers with experimental animals, disease model animals, as well as animal medicine, pesticide, and medical device evaluation services.
Zhaoyan New Drug adheres to the principle of "serving drug innovation, focusing on safety evaluation and monitoring of the entire drug life cycle". With the comprehensive strength of modern medicine and multiple disciplines, rich experience accumulated over the past 30 years, and persistent efforts, we provide professional services for new drug non clinical trials, clinical trials, and new drug registration to our customers, ensuring patient medication safety and caring for human health.